slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
234,091-234,120 of 319,975
30
The slide uses a color-coded sidebar on the right to categorize the drug's development stage (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
31
The slide provides a structured overview of five specific clinical trials (TROPION-Breast01 through 05).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
32
The slide is part of an appendix, indicated by the footer and the 'Appendix' label.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
33
The slide is part of an appendix, specifically detailing late-stage development assets in Oncology.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
34
The slide is part of an appendix, indicated by the page number 34 and the 'Appendix: Glossary' link at the bottom.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
35
The slide is part of an appendix section, indicated by the page number and glossary link.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
36
The slide is part of an appendix, detailing specific trial designs, patient counts, and status for TROPION-PanTumor trials.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
37
The slide uses a vertical navigation bar on the right to indicate the drug's development stage (Late-stage development) and therapeutic area (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
38
Includes trial identifiers (NCT numbers) and status timelines.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
39
The slide is an appendix page detailing clinical trial pipeline data for a specific drug.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
40
The table lists five distinct clinical trials (SERENA-2, SERENA-3, NCT04541433, SERENA-1, NCT04818632).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
41
The slide is part of an appendix section detailing clinical trial pipelines.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
42
The slide is part of an appendix, specifically detailing late-stage development assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
43
The slide is part of an appendix, providing detailed clinical trial data for a specific asset.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
44
The slide provides a structured overview of four specific clinical trials (EvoPAR-Prostate01, EvoPAR-Breast01, PETRA, PETRANHA).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
45
The slide is part of an appendix, providing specific clinical trial data for a drug candidate.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
46
The slide is an appendix page detailing the clinical development pipeline for a specific drug candidate.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
47
Slide 47 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
48
AstraZeneca | Results Presentation Deck | 157 slidesAstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
49
Slide 49 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
50
Part of a pipeline appendix deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
51
Slide 51 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
52
Part of a larger portfolio deck, indicated by the vertical navigation bar on the right.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
53
The slide is part of an appendix, providing detailed clinical trial data for a specific drug candidate.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
54
Slide 54 of a larger deck, part of the appendix.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
55
Slide 55 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
56
Part of a clinical pipeline appendix.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
57
The slide provides a summary of two clinical trials (PRIMROSE and PRIMAVERA) including population, patient counts, design, endpoints, and status.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
58
Part of a corporate presentation appendix, specifically under the Oncology pipeline section.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
59
The slide uses a standard clinical trial table format common in pharmaceutical investor presentations.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit